Anzeige
Meldung des Tages: Bohrtreffer, Infrastruktur, Finanzierung: Beginnt hier der Weg zur Produktion?

Abivax News

Aktie
WKN:  A14UQC ISIN:  FR0012333284 US-Symbol:  AAVXF Branche:  Biotechnologie Land:  Frankreich
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Marktkapitalisierung *
7,46 Mrd. €
Streubesitz
54,81%
KGV
-2,41
Index-Zuordnung
-

Abivax News

25.07.25 - EQS
EQS-News: Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
EQS-News: ABIVAX / Key word(s): Capital Increase Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to ...
24.07.25 - EQS
EQS-News: Abivax announces trading resumption of its ordinary shares on Euronext Paris
EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax announces trading resumption of its ordinary shares on Euronext Paris 24.07.2025 / 14:40 CET/CEST The issuer is solely ...
24.07.25 - EQS
EQS-News: Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares
EQS-News: ABIVAX / Key word(s): Capital Increase Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares 24.07.2025 / 14:40 CET/CEST The ...
24.07.25 - EQS
EQS-News: Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax announces temporary trading halt of its ordinary shares on Euronext Paris 24.07.2025 / 07:30 CET/CEST The issuer is ...
23.07.25 - EQS
EQS-News: Abivax Announces Launch of Public Offering
EQS-News: ABIVAX / Key word(s): Financing Abivax Announces Launch of Public Offering 23.07.2025 / 22:15 CET/CEST The issuer is solely responsible for the content of this ...
22.07.25 - EQS
EQS-News: Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
EQS-News: ABIVAX / Key word(s): Study results/Study Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-...
11.06.25 - EQS
EQS-News: Abivax Announces Results of its June 6, 2025 Annual General Meeting
EQS-News: ABIVAX / Key word(s): AGM/EGM Abivax Announces Results of its June 6, 2025 Annual General Meeting 11.06.2025 / 22:00 CET/CEST The issuer is solely responsible ...
02.06.25 - EQS
EQS-News: Abivax Presents First Quarter 2025 Financial Results
EQS-News: ABIVAX / Key word(s): Quarter Results Abivax Presents First Quarter 2025 Financial Results 02.06.2025 / 22:00 CET/CEST The issuer is solely responsible for the ...
29.04.25 - EQS
EQS-News: Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
EQS-News: ABIVAX / Key word(s): Study Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis ...
22.04.25 - EQS
EQS-News: Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
EQS-News: ABIVAX / Key word(s): AGM/EGM Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-​Driving Milestones 22.04.2025 / ...
22.04.25 - EQS
EQS-News: Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors 22.04.2025 / 22:00 CET/CEST The issuer is solely ...

Newssuche

Videos

newspaper
09:50 Uhr +0,05%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »